MORE►
Caris Life Sciences
ConcertAI CEO Jeff Elton (left) and David Spetzler, president of Caris Life Sciences [Photo: ConcertAI]
Caris Life Sciences and ConcertAI Announce New Clinico-Genomic Research Platform
by Lance Murray | Jun 1, 2023
Expanding a collaboration they announced in January, the two companies aim to drive "the future of cancer care" with the new platform, enabling novel insights for precision medicine, therapeutic development, and clinical trials management for academic and biopharma researchers.
by Dallas Innovates | Staff Report |
Mar 1, 2023
Dallas-Fort Worth is well known for its tech expertise. Now it being recognized as the place where technology meets life science—a convergence that’s driving rapid growth in the biotech ecosystem....
MORE►
by Lance Murray |
Jan 17, 2023
Dallas Innovates and D CEO celebrated 68 honorees and revealed the winners of our fourth-annual Innovation Awards at an event held at On the Levee in the Dallas Design District.
Here's a full list of winners and finalists.
MORE►
by Lance Murray |
Nov 3, 2022
Now in its fourth year, the program from Dallas Innovates and D CEO honors 68 disruptors and trailblazers driving a new vision for innovation in North Texas.
Finalists will be recognized in the January/February issue of D CEO magazine and online at DallasInnovates.com. Winners will be revealed at an exclusive awards event in January.
MORE►
DI People: UNT Health Science Center, McKesson, Cyrus One, and More Make Leadership Moves
by Lance Murray | Sep 16, 2022
In this week’s roundup of hires, promotions, and accolades in North Texas, you’ll also find news from Jacobs, HF Sinclair and Holly Energy Partners, Caris Life Sciences, Fossil Group, Deloitte, TRG, Invited, Instil Bio, RealPage, Critical Start, Genuine Article, and others.
MORE►
by Alex Edwards |
Oct 27, 2020
The growth capital will allow Caris to advance its position as a leading tumor profiling company that aims to reinvent cancer care.
MORE►
by Alex Edwards |
Oct 9, 2020
In this week's roundup of hires and promotions in North Texas, you'll also find news from NuZee, Imaginuity, HudsonLake, ALTO Real Estate Funds, AMN Healthcare, Caris Life Sciences, and more.
MORE►
DI People: Jacobs, Caris Life Sciences, Infogroup, and One Network Enterprises Make Leadership Moves
by Lance Murray |
Feb 11, 2020
In this weekly roundup of leadership and executive moves by companies and organizations in North Texas, you’ll also find news from AspireHR, Rent-A-Center, Jones|Carter, and Kane Russell Coleman Logan.
MORE►
[Photo: vitanovski via iStock]
Caris Life Sciences Launches AI-Driven Profiling Tool for Tumors
by Lance Murray | Dec 12, 2019
The Genomic Profiling Similarity Score uses over 6,500 mathematical models in a machine learning algorithm to compare molecular characteristics of a patient's tumor against Caris' extensive database.
MORE►
by Lance Murray |
Dec 6, 2019
In this weekly roundup of research and development activity in North Texas, you’ll also read about how Caris Life Sciences is offering a new tool to evaluate hereditary cancer risks.
MORE►
by Alex Edwards |
Aug 20, 2019
The Caris Life Sciences Corporate Park in Irving will increase R&D capabilities with a state-of-the-art precision medicine laboratory, create more than 500 jobs in the region, and help Caris continue to "reinvent cancer care."
MORE►
by Lance Murray |
Jul 9, 2019
You’ll also find news from Antuit, Texas Women’s Foundation, Brinks Home Security, Pharos Capital, Texas CASA, and Bracewell LLP in this roundup of executive and leadership announcements by companies and organizations in North Texas.
MORE►
[Photo: via NatChittamai/iStockphoto]
Discovery: UTA Team Creating Water Modeling Tool for Trinity River; UTSW Finds How ‘Bad Cholesterol’ Enters Artery Walls
by Lance Murray | May 3, 2019
You'll also find out about how the FDA has granted Breakthrough Device status to a new Caris Life Sciences cancer test in this roundup of research and development activity in North Texas.
MORE►
by Payton Potter |
May 2, 2019
Using a patient's molecular makeup, Caris and Pharmatech aim to find the perfect clinical trial for each cancer patient—and enroll them in as little as 10 days.
MORE►
by Lance Murray |
Mar 29, 2019
You'll also find out about Caris Life Sciences' data that shows a novel pathway to treating Non-Hodgkins lymphoma in this roundup of research and development activity in North Texas.
MORE►
by Lance Murray |
Feb 15, 2019
Regardless of what type of funding it is—seed, venture capital, angel, or corporate—here are 17 North Texas companies that successfully pulled in capital to back their ventures.
MORE►
